Ginsenoside Rg1 improves fertility and reduces ovarian pathological damages in premature ovarian failure model of mice

Feb 10, 2017Experimental biology and medicine (Maywood, N.J.)

Ginsenoside Rg1 improves fertility and reduces ovary damage in a mouse model of early ovarian failure

AI simplified

Abstract

Ginsenoside Rg1 significantly improved body weight and restored ovarian function in a mouse model of premature ovarian failure induced by d-galactose.

  • Rg1 treatment led to a release of estrous cycle block compared to the d-galactose group.
  • Fertility and ovarian morphology were restored in the Rg1 + d-gal group.
  • Rg1 administration significantly reduced the expression of senescence-associated proteins.
  • The activity of antioxidant enzymes, total superoxide dismutase and glutathione peroxidase, was increased with Rg1 treatment.
  • Levels of pro-inflammatory markers such as interleukin-1β, tumor necrosis factor-α, and interleukin-6 were significantly decreased after Rg1 treatment.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free